Lindbrook Capital, LLC Biomarin Pharmaceutical Inc Transaction History

Lindbrook Capital, LLC

$1.06 Billion
Q2 2024

A detailed history of Lindbrook Capital, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 278 shares of BMRN stock, worth $19,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares

278

Previous 314 11.46%

Holding current value

$19,621

Previous $27,000 18.52%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$74.43 - $92.22 $2,679 - $3,319	-36 Reduced 11.46%	278 $22,000
Q1 2024 Apr 25, 2024	SELL	$83.81 - $99.0 $5,950 - $7,029	-71 Reduced 18.44%	314 $27,000
Q4 2023 Jan 31, 2024	BUY	$76.22 - $98.51 $21,189 - $27,385	278 Added 259.81%	385 $37,000
Q3 2023 Oct 25, 2023	SELL	$85.07 - $94.48 $935 - $1,039	-11 Reduced 9.32%	107 $9,000
Q2 2023 Jul 28, 2023	BUY	$86.68 - $100.3 $86 - $100	1 Added 0.85%	118 $10,000
Q1 2023 Apr 26, 2023	BUY	$87.74 - $117.27 $2,018 - $2,697	23 Added 24.47%	117 $11,000
Q4 2022 Jan 24, 2023	SELL	$80.93 - $108.63 $7,688 - $10,319	-95 Reduced 50.26%	94 $0
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $8,051 - $9,500	98 Added 107.69%	189 $16,000
Q2 2022 Aug 01, 2022	BUY	$71.48 - $86.85 $1,358 - $1,650	19 Added 26.39%	91 $8,000
Q1 2022 Apr 21, 2022	SELL	$74.28 - $92.69 $742 - $926	-10 Reduced 12.2%	72 $6,000
Q4 2021 Jan 18, 2022	BUY	$71.72 - $91.47 $3,227 - $4,116	45 Added 121.62%	82 $7,000
Q3 2021 Nov 05, 2021	BUY	$74.77 - $85.47 $224 - $256	3 Added 8.82%	37 $3,000
Q2 2021 Jul 27, 2021	BUY	$75.51 - $84.79 $377 - $423	5 Added 17.24%	34 $3,000
Q1 2021 Apr 28, 2021	SELL	$74.73 - $90.69 $4,932 - $5,985	-66 Reduced 69.47%	29 $2,000
Q4 2020 Jan 27, 2021	BUY	$72.61 - $90.2 $3,703 - $4,600	51 Added 115.91%	95 $8,000
Q3 2020 Nov 03, 2020	BUY	$71.87 - $131.03 $143 - $262	2 Added 4.76%	44 $3,000
Q2 2020 Jul 27, 2020	BUY	$79.55 - $124.22 $477 - $745	6 Added 16.67%	42 $5,000
Q1 2020 Apr 22, 2020	BUY	$71.37 - $96.85 $713 - $968	10 Added 38.46%	36 $3,000
Q4 2019 Jan 27, 2020	SELL	$64.27 - $86.37 $4,434 - $5,959	-69 Reduced 72.63%	26 $2,000
Q3 2019 Oct 31, 2019	SELL	$67.4 - $85.11 $19,748 - $24,937	-293 Reduced 75.52%	95 $6,000
Q2 2019 Jul 24, 2019	BUY	$80.35 - $93.9 $2,089 - $2,441	26 Added 7.18%	388 $33,000
Q4 2018 Feb 07, 2019	BUY	$80.14 - $106.07 $29,010 - $38,397	362 New	362 $30,000

Others Institutions Holding BMRN

# of Institutions

632

Shares Held

185M

Call Options Held

1.63M

Put Options Held

1.2M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.

Account

Lindbrook Capital, LLC Biomarin Pharmaceutical Inc Transaction History